| Message | Subject | Recs | Date/Time (ET) |
| Thanks for the response. I will state upfront that I am no doctor and no expert | Guidant (GDT) | | 09/04/2002 10:23:42 AM |
| I think MDT is an outstanding company. The price however is a bit too rich for m | Guidant (GDT) | | 09/03/2002 11:13:07 AM |
| Mid quarter call tightens ranges at the upper end of estimates. Look for $2.08 a | Guidant (GDT) | | 08/29/2002 10:18:03 AM |
| Cook really gives GDT just two main drivers - The AAA graft and the paclitaxel s | Boston Scientific (BSX) Any Comments??? | | 08/05/2002 09:36:01 AM |
| No comments on yesterday's GDT announcement? This certainly takes some of the up | Boston Scientific (BSX) Any Comments??? | | 07/31/2002 04:19:13 PM |
| Sooner rather than later. Conference call should be interesting.
GUIDANT AGRE | Guidant (GDT) | | 07/30/2002 10:39:20 AM |
| Everolimus is the only announced internal program with GDT. They have stated tha | Guidant (GDT) | | 07/22/2002 09:58:16 AM |
| Now that was a strong quarterly report!
The ICD numbers were awesome. I now g | Guidant (GDT) | | 07/19/2002 11:28:00 AM |
| I may be completely wrong, but earnings estimates for BSX are about to be reconf | Boston Scientific (BSX) Any Comments??? | | 07/01/2002 11:54:52 AM |
| Do not believe everything you read from posters. I could be stupid, lazy and mos | Guidant (GDT) | | 06/20/2002 04:09:19 PM |
| This stock again has appeal top me; however, has anyone got an idea of the conti | Boston Scientific (BSX) Any Comments??? | | 06/18/2002 01:52:07 PM |
| Break out the wallet boys. Cook will not be cheap to buy now.
UPDATE 1-U | Guidant (GDT) | | 06/13/2002 01:34:37 PM |
| "Guidant was awarded $158 million in damages plus interest and costs. The arbitr | Guidant (GDT) | | 04/26/2002 11:18:03 AM |
| Sepracor Inc. Sets Conference Call and Webcast for First Quarter 2002 Results
| Sepracor-Looks very promising | | 04/11/2002 02:15:05 PM |
| Scratch the small niche acquisition talk. Much more likely that GDT is talking t | Guidant (GDT) | | 03/07/2002 03:04:31 PM |
| Also wondering if GDT is going to get back into the small niche company acquisit | Guidant (GDT) | | 01/11/2002 11:20:28 AM |
| Nice presentation by GDT at the recent H&Q conference out in San Fran. Anyone in | Guidant (GDT) | | 01/10/2002 09:57:07 PM |
| Merck finally fesses up to the patent expiration problem that lots of people hav | Merck | | 12/11/2001 04:06:57 PM |
| I exited the stock a point or two ago. Probably early but I will take my gain. I | Boston Scientific (BSX) Any Comments??? | | 11/29/2001 02:31:24 PM |
| Yes they certainly did. I hate to beat a dead horse, but it is true IMHO: Wall S | Guidant (GDT) | | 11/24/2001 12:06:02 PM |
| Very good news IMHO. Should help entail GDT passing estimates for the next few y | Guidant (GDT) | | 11/21/2001 02:58:50 PM |
| 1)Hmmmmmm no news and a very, very strong stock.
2)Peter Nicholas steps bac | Boston Scientific (BSX) Any Comments??? | | 11/20/2001 02:03:57 PM |
| NEW YORK (Dow Jones)--Sepracor Inc.'s (SEPR) $400 million convertible
offering | Sepracor-Looks very promising | | 11/08/2001 04:23:01 PM |
| Lots of moving parts in this release:
http://www.siliconinvestor.com/research | Incyte Pharmaceuticals (INCY) | | 10/25/2001 09:27:30 AM |
| BSX is not without some big problems of their own, so at these "fair value" leve | Boston Scientific (BSX) Any Comments??? | | 10/04/2001 02:37:22 PM |
| BSX continues to climb - now approaching "fair value" on my models. Quite a cha | Boston Scientific (BSX) Any Comments??? | | 10/04/2001 10:42:42 AM |
| Not much to add, but I was struck reading through the 10Q at the balance sheet m | Incyte Pharmaceuticals (INCY) | | 09/26/2001 02:11:46 PM |
| No one knows how long the 0% level will last, but it appears to work much better | Boston Scientific (BSX) Any Comments??? | | 09/25/2001 11:27:17 AM |
| The BSX/MDT Rapid Exchange court battle will throw some business toward GDT. Ver | Guidant (GDT) | | 09/19/2001 10:23:33 AM |
| BSX catches a bone from the courts.
I thought MDT and BSX would settle this | Boston Scientific (BSX) Any Comments??? | | 09/19/2001 10:18:09 AM |
| JNJ's data bring up some thorny issues:
JNJ will rapidly take at least 80% ma | Guidant (GDT) | | 09/05/2001 10:19:03 AM |
| JNJ data on coated stents better than expected. Most forecasters were looking fo | Guidant (GDT) | | 09/04/2001 02:57:18 PM |
| Not quite an outright acquisition, but serves the same purpose.
"Cook(R) Inc | Guidant (GDT) | | 08/21/2001 08:50:56 AM |
| BSX trying to crawl out of the swamp in the 2nd QTR.
Tobin's blocking & tackl | Boston Scientific (BSX) Any Comments??? | | 07/19/2001 12:13:32 PM |
| I am sure our friends at GDT saw the Cook news yesterday. Here is a swipe from a | Guidant (GDT) | | 07/17/2001 10:07:21 AM |
| I doubt GDT gets FDA approval on the first go. Not good, but certainly not that | Guidant (GDT) | | 07/11/2001 10:16:28 PM |
| Well now everyone hates Guidant? Downgrades galore this morning. Lowered price t | Guidant (GDT) | | 07/11/2001 09:48:20 AM |
| diaDexus S-1 still sitting on the launch pad . . . waiting for the go code. ht | Incyte Pharmaceuticals (INCY) | | 05/23/2001 03:50:04 PM |
| Apologies for jumping in.
GLGC might pose a bit of a problem in that they hav | Biotech Valuation | | 05/11/2001 03:43:45 PM |
| This makes for an amazing
read:http://www.siliconinvestor.com/research/story.g | Boston Scientific (BSX) Any Comments??? | | 04/05/2001 03:33:07 PM |
| Medical. | Boston Scientific (BSX) Any Comments??? | | 03/26/2001 01:34:00 PM |
| Maybe. (What a whimmpy answer)
I suspect the ability to move above $20 convin | Boston Scientific (BSX) Any Comments??? | | 03/26/2001 09:25:35 AM |
| TA is not my bag and I would just be guessing if I gave a reply.
The followin | Incyte Pharmaceuticals (INCY) | | 03/22/2001 10:17:49 PM |
| The following is pure conjecture and subject to the delusions of the author. Ple | Incyte Pharmaceuticals (INCY) | | 03/22/2001 08:54:27 AM |
| If I could buy the entire company for $170,000,000 or so technology value would | Incyte Pharmaceuticals (INCY) | | 03/21/2001 03:16:49 PM |
| I do not mean to intrude, but I have been running these numbers myself the past | Incyte Pharmaceuticals (INCY) | | 03/21/2001 02:39:27 PM |
| Vector 1 and Thread,
A while back you mentioned the possibility of adding one | VD's Model Portfolio & Discussion Thread | | 03/08/2001 01:40:06 PM |
| By far, Quanam Medical Corporation is the best of the recent acquisitions IMHO. | Boston Scientific (BSX) Any Comments??? | | 03/02/2001 10:51:18 AM |
| Ridley's book is an easy read. Way too simplistic for most truly informed scient | Biotech Valuation | | 02/26/2001 01:54:30 PM |
| Simplistic market cap equals total shares times price per share. The number of s | Incyte Pharmaceuticals (INCY) | | 02/14/2001 04:02:21 PM |
Copyright © 1995-2013 Knight Sac Media. All rights reserved.
